APP and Alzheimer disease: Such Aβ seeding was first reported in the early 2000s by Lary Walker and colleagues, who described Aβ aggregation in the brain parenchyma of APP-transgenic mice intracerebrally inoculated with Aβ-rich extracts from patients with AD disease [153,154].